{"id":356841,"date":"2010-02-24T04:49:33","date_gmt":"2010-02-24T09:49:33","guid":{"rendered":"http:\/\/itecsinsider.com\/?p=13938"},"modified":"2010-02-24T04:49:33","modified_gmt":"2010-02-24T09:49:33","slug":"nih-solicitations-february-week-3","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/356841","title":{"rendered":"NIH Solicitations February Week 3"},"content":{"rendered":"

\"nih-small2\"Grants for Research in Glomerular Disease <\/strong>\u2013 This FOA invites applications from investigators with diverse scientific interests to apply their expertise to enhance the understanding of the pathogenesis of the various primary or secondary forms of glomerular disease. Recent observations regarding intrinsic glomerular cell biology, particularly in the podocyte, have provided exciting new insights into potential pathogenic mechanisms of human glomerular disease. It is anticipated that applications submitted in response to this FOA could address a number of different aspects concerning the pathogenesis, natural history, therapy, pre-emption, or prevention of the various morphologic forms of experimental glomerular disease. <\/span>Relevant topics of study for research evaluating glomerular disease could include (but are not limited to): 1) Understanding basic glomerular cell biology; 2) Understanding pathogenic mechanisms of specific forms of glomerular disease; 3) Development of new animal models for specific forms of glomerular disease; 4) Development of new glomerular-specific imaging techniques; 5) Identification and characterization of glomerular disease biomarkers; 6) Assessing the mechanisms underlying the increased disease incidence associated with susceptibility genes; 7)\u00a0 Developing tools and\/or techniques to enhance the diagnosis and\/or\u00a0 therapy of human glomerular diseases 8 ) Developing tools to enhance the prognostic accuracy of human glomerular diseases given different baseline risk factors or under different therapeutic strategies.\u00a0 Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. Eligibility: All. Opening Date: May 5, 2010.\u00a0 Closing Dates: June 5, annually and October 5, annually.\u00a0 Expires: May 8, 2013.<\/span><\/p>\n

Posted Date: February 22, 2010<\/span><\/p>\n

Solicitation Number: PA-10-113 <\/a><\/span><\/p>\n

————————————————————————————–
\n<\/span><\/p>\n

Development of Outcome Measures to Determine Success of Hearing Health Care (R01) \u2013<\/strong> This FOA, issued by the National Institute on Deafness and Other Communication Disorders, NIH, encourages R01 applications from institutions\/organizations that propose to develop and evaluate a set of outcome measures to determine the success of hearing health care for adults with hearing loss.\u00a0 There is a compelling need to identify the variables contributing to successful hearing health care outcomes, particularly the patient-centered and instrument-centered variables contributing to successful hearing aid use.\u00a0 This FOA encourages Community-Based Research practices and encourages inclusion and attention to the needs of special populations (elderly, low SES, disparities, rural, second language populations).\u00a0\u00a0 Eligibility: All.\u00a0 Opening Date: September 1, 2010.\u00a0 LOI Due Dates: September 1, 2010, May 1, 2011, January 1, 2012.\u00a0 Application Due Dates: October 1, 2010, June 1, 2011, February 1, 2012.<\/span><\/p>\n

Posted Date: February 19, 2010<\/span><\/p>\n

Program Announcement (PA) Number: PAR-10-112<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

Grants for Research in Glomerular Disease \u2013 This FOA invites applications from investigators with diverse scientific interests to apply their expertise to enhance the understanding of the pathogenesis of the various primary or secondary forms of glomerular disease. Recent observations regarding intrinsic glomerular cell biology, particularly in the podocyte, have provided exciting new insights into […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-356841","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/356841","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=356841"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/356841\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=356841"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=356841"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=356841"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}